Changchun Institute of Biological Products Co., Ltd.
Establishment time : 1941
website : http://www.cibp.cncn.com/
Main Product : Vaccines, biological products
Company Profile
Changchun Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. With a history dating back to 1941, the company has established a strong presence in both domestic and international markets. With a large company size and a focus on innovation, CIBP continues to be a key player in the pharmaceutical industry.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : www.cdibp.com
Main Product : Biological products, vaccines, diagnostic reagents
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines, biological products, and diagnostic reagents. With a history dating back to 1967, the company has grown to become a major player in the healthcare industry, serving both domestic and international markets. With a large workforce of over 1,000 employees, the company is known for its high-quality products and commitment to innovation.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : Wuhan Institute of Biological Products Co., Ltd. was founded in 1967 and has since become a leading manufacturer of vaccines and biological products.
website : http://www.whbp.com.cn/, where cu
Main Product : Wuhan Institute of Biological Products Co., Ltd. produces a wide range of vaccines and biological products to meet the needs of both domestic and international markets.
Company Profile
Overall, Wuhan Institute of Biological Products Co., Ltd. is dedicated to providing high-quality vaccines and biological products to improve public health worldwide.
Beijing Tiantan Biological Products Co., Ltd.
Establishment time : 1992
website : www.btbp.com.cn
Main Product : vaccines, blood products, diagnostic reagents
Company Profile
Beijing Tiantan Biological Products Co., Ltd. is a renowned biopharmaceutical company specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. Established in 1992, the company has grown to become a key player in the industry, with a large workforce and a strong presence in both domestic and international markets. With a commitment to innovation and quality, Beijing Tiantan Biological Products Co., Ltd. continues to make significant contributions to public health and disease prevention.
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2007
website : www.lncdbio.com
Main Product : Probiotics, enzymes, feed additives
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. is a leading biotechnology company specializing in the research, development, and production of probiotics, enzymes, and feed additives. Established in 2007, the company has grown to become a key player in the industry, serving markets in China, Southeast Asia, and the Middle East. With a medium-sized workforce, Liaoning Chengda Biotechnology faces strong competition in the market but continues to innovate and expand its product offerings to meet the needs of its customers. Visit their website at www.lncdbio.com for more information.
Hualan Biological Engineering Inc.
Establishment time : Hualan Biological Engineering Inc. was founded in 1993 and has since become a leading biopharmaceutical company in China.
website :
Main Product : With a medium-sized company size, Hualan Biological Engineering Inc. has established a strong presence in both the domestic and international markets.
Company Profile
Through its commitment to quality and innovation, Hualan Biological Engineering Inc. remains a trusted provider of biopharmaceutical solutions worldwide.
July 28, 2024
